ANIX

Anixa Biosciences (ANIX)

About Anixa Biosciences (ANIX)

Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology and infectious disease. It operates through the following segments: CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics, and Other. The CAR-T Therapeutics segment involves the development of immuno-therapy drugs against cancer. The Cancer Vaccines segment includes the early stages development of immunization for breast and ovarian cancer. The company was founded on November 5, 1982 and is headquartered San Jose, CA.

Details

Daily high
$2.69
Daily low
$2.58
Price at open
$2.64
52 Week High
$5.13
52 Week Low
$2.14
Market cap
86.6M
Dividend yield
0.00%
Volume
96,128
Avg. volume
83,676
P/E ratio
-6.89

Anixa Biosciences News

Details

Daily high
$2.69
Daily low
$2.58
Price at open
$2.64
52 Week High
$5.13
52 Week Low
$2.14
Market cap
86.6M
Dividend yield
0.00%
Volume
96,128
Avg. volume
83,676
P/E ratio
-6.89